Active substance | difelikefalin |
Holder | Vifor Fresenius Medical Care Pharma Ltd |
Status | closed |
Indication | treatment of moderate to severe chronic kidney disease-associated pruritus (CKD-aP) in adults undergoing hemodialysis (HD) |
Public documents | Approbation |
Information for the patient | |
Informed consent | |
Last update | 30/01/2024 |